Skip to main content
    S

    SAB Biotherapeutics Inc (SABS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.00
    +0.04 (+1.35%)

    Market Cap: $266.66M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    SAB Biotherapeutics Inc (SABS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to SAB Biotherapeutics are Palisade Bio (PALI), Precision BioSciences (DTIL) and Cartesian Therapeutics (RNAC). By market cap, SAB Biotherapeutics ranks 5th of the 13 companies on this page; Sana Biotechnology (SANA) is the largest at $605.26M.

    Peer Comparison

    SABS's revenue growth of -62.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    SAB Biotherapeutics (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Palisade Bio Inc (PALI)$201.01MN/A436.8x0.0%N/A0.0%0.00%
    Precision BioSciences Inc (DTIL)$288.76MN/A4.4x-85.6%-38.3%37272.0%0.00%
    Cartesian Therapeutics Inc. (RNAC)$193.69MN/A179.8x0.0%147.2%-92.9%0.00%
    Q32 Bio Inc (QTTB)$260.64M2.5x5.2x60.0%N/A0.0%0.00%
    Invivyd Inc. (IVVD)$171.58MN/A2.9x-183.9%N/A21.2%0.00%
    Sana Biotechnology Inc (SANA)$605.26MN/AN/A0.0%-46.8%0.0%0.00%
    Sutro Biopharma (STRO)$163.03MN/A3.4x0.0%N/A-6.1%0.00%
    Upstream Bio, Inc. (UPB)$152.38MN/A41.0x0.0%N/A-42.2%0.00%
    Greenwich Lifesciences Inc (GLSI)$219.29MN/AN/A0.0%N/A0.0%0.00%
    Shattuck Labs Inc (STTK)$473.57MN/AN/A0.0%N/A-66.6%0.00%
    Tevogen Bio Holdings Inc. (TVGN)$406.59MN/AN/A0.0%2022.8%0.0%0.00%
    Atrium Therapeutics, Inc. Common Stock (RNA)$162.00MN/A3.3x-180.9%-44.5%24.2%0.00%
    Peer median$210.15M2.5x4.8x0.0%-38.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to SAB Biotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Palisade Bio Inc (PALI)
    Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier.
    PALI competitors
    Precision BioSciences Inc (DTIL)
    Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States.
    DTIL competitors
    Cartesian Therapeutics Inc. (RNAC)
    Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs...
    RNAC competitors
    Q32 Bio Inc (QTTB)
    Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune...
    QTTB competitors
    Invivyd Inc. (IVVD)
    Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery...
    IVVD competitors
    Sana Biotechnology Inc (SANA)
    Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
    SANA competitors
    Sutro Biopharma (STRO)
    Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company.
    STRO competitors
    Upstream Bio, Inc. (UPB)
    Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders.
    UPB competitors
    Greenwich Lifesciences Inc (GLSI)
    Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /...
    GLSI competitors
    Shattuck Labs Inc (STTK)
    Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States.
    STTK competitors
    Tevogen Bio Holdings Inc. (TVGN)
    Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology...
    TVGN competitors
    Atrium Therapeutics, Inc. Common Stock (RNA)
    Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies.
    RNA competitors

    Frequently Asked Questions About SABS

    Who are SAB Biotherapeutics' main competitors?

    The companies most similar to SAB Biotherapeutics include Palisade Bio (PALI), Precision BioSciences (DTIL), Cartesian Therapeutics (RNAC), Q32 Bio (QTTB) and Invivyd (IVVD), listed from the closest match.

    Who is SAB Biotherapeutics' biggest competitor?

    Sana Biotechnology (SANA) is the largest of the similar companies at $605.26M; Palisade Bio (PALI) is the closest match by business profile, size, sector and industry.

    How does SABS stock compare with its competitors?

    SABS' net margin is 0.0% against a peer median of 0.0%.

    Which of SAB Biotherapeutics' competitors pays a higher dividend?

    SAB Biotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is SAB Biotherapeutics bigger than its competitors?

    No. SAB Biotherapeutics is 5th by market cap among the 13 companies on this page; the largest is Sana Biotechnology (SANA) at $605.26M.